Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Karavitaki

Showing results (1-10 of 27) with videos related to

Pageof 3
Sort By:
Pituitary|April 5, 2008
Radiotherapy of other sellar lesionsN Karavitaki
Journal of Endocrinological Investigation|January 31, 2014
Management of craniopharyngiomasN Karavitaki
Pituitary|September 16, 2019
Dopamine agonist resistant prolactinomas: any alternative medical treatment?P Souteiro, N Karavitaki
Clinical Endocrinology|January 17, 2004
Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndromeN Karavitaki, G Ioannidis, F Giannakopoulos, et al.
QJM : Monthly Journal of the Association of Physicians|November 23, 2012
Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognizedA Rogers, L M Wang, N Karavitaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
A case of post-traumatic isolated ACTH deficiency with spontaneous recovery 9 months after the eventN Karavitaki, J Wass, J D Henderson Slater, et al.
Annals of the Royal College of Surgeons of England|October 6, 2018
Surgery for Cushing's disease in pregnancy: our experience and a literature reviewK Jolly, A Darr, W Arlt, et al.
Clinical Endocrinology|March 27, 2009
The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegalyN Karavitaki, A Fernandez, V Fazal-Sanderson, et al.
Clinical Endocrinology|September 28, 2011
Disconnection hyperprolactinaemia in nonadenomatous sellar/parasellar lesions practically never exceeds 2000 mU/lT Korevaar, J A H Wass, A B Grossman, et al.
QJM : Monthly Journal of the Association of Physicians|December 16, 2011
IGF2-induced hypoglycemia unresponsive to everolimusT I M Korevaar, F Ragazzoni, A Weaver, et al.
Pageof 3

Showing results (1-10 of 27) with videos related to

Sort By:
Pageof 3
Pituitary|April 5, 2008
Radiotherapy of other sellar lesionsN Karavitaki
Journal of Endocrinological Investigation|January 31, 2014
Management of craniopharyngiomasN Karavitaki
Pituitary|September 16, 2019
Dopamine agonist resistant prolactinomas: any alternative medical treatment?P Souteiro, N Karavitaki
Clinical Endocrinology|January 17, 2004
Evaluation of bone mineral density of the peripheral skeleton in pre- and postmenopausal women with newly diagnosed endogenous Cushing's syndromeN Karavitaki, G Ioannidis, F Giannakopoulos, et al.
QJM : Monthly Journal of the Association of Physicians|November 23, 2012
Neurofibromatosis Type 1 and pancreatic islet cell tumours: an association which should be recognizedA Rogers, L M Wang, N Karavitaki, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|January 20, 2006
A case of post-traumatic isolated ACTH deficiency with spontaneous recovery 9 months after the eventN Karavitaki, J Wass, J D Henderson Slater, et al.
Annals of the Royal College of Surgeons of England|October 6, 2018
Surgery for Cushing's disease in pregnancy: our experience and a literature reviewK Jolly, A Darr, W Arlt, et al.
Clinical Endocrinology|March 27, 2009
The value of the oral glucose tolerance test, random serum growth hormone and mean growth hormone levels in assessing the postoperative outcome of patients with acromegalyN Karavitaki, A Fernandez, V Fazal-Sanderson, et al.
Clinical Endocrinology|September 28, 2011
Disconnection hyperprolactinaemia in nonadenomatous sellar/parasellar lesions practically never exceeds 2000 mU/lT Korevaar, J A H Wass, A B Grossman, et al.
QJM : Monthly Journal of the Association of Physicians|December 16, 2011
IGF2-induced hypoglycemia unresponsive to everolimusT I M Korevaar, F Ragazzoni, A Weaver, et al.
Pageof 3